touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • RAS mutations and personalized cancer care: Targeting the future

    touchEXPERT OPINIONS for touchONCOLOGY

    Listen to a medical oncologist, a pancreatic cancer specialist and a lung cancer specialist discuss the role of RAS mutations in solid tumours, notably pancreatic cancer and NSCLC, and how they may be therapeutically targeted to improve patient outcomes.

    The experts

    • Dr David S Hong, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    • Dr Eileen M O’Reilly, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA
    • Dr Rebecca S Heist, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

      • This touchPODCAST is for healthcare professionals outside of the UK.

       

      This activity is funded by an independent medical education grant from Revolution Medicines.

       

      This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

       

      For further information visit our website: 

      https://touchoncologyime.org/mutations-and-personalized-cancer-care-targeting-the-future/

       

      32 min
    • What’s new in primary ITP? Key updates from ASH 2024

      touchPANEL DISCUSSION for touchONCOLOGY

      Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.  

      The experts

      • Dr Hanny Al-Samkari – Massachusetts General Hospital, Boston, MA, USA
      • Dr Drew Provan – Barts and The London School of Medicine and Dentistry, London, UK
      • Dr Barbara Skopec – University Medical Centre Ljubljana, Ljubljana, Slovenia

        • This touchPODCAST is for HCPs outside of the UK only.

        This activity is funded by an independent medical education grant from Sanofi.

        This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider.

        For further information visit our website:

        https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#

        41 min
      • What’s new in primary ITP? Key updates from ASH 2024

        touchPANEL DISCUSSION for touchHAEMATOLOGY

        Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.  

        The experts

        • Dr Hanny Al-Samkari – Massachusetts General Hospital, Boston, MA, USA
        • Dr Drew Provan – Barts and The London School of Medicine and Dentistry, London, UK
        • Dr Barbara Skopec – University Medical Centre Ljubljana, Ljubljana, Slovenia

          • This touchPODCAST is for HCPs outside of the UK only.

          This activity is funded by an independent medical education grant from Sanofi.

          This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider.

          For further information visit our website:

          https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#

          41 min
        • Focused insights: Data implications of ADCs in NSCLC treatment

          touchFOCUS for touchRESPIRATORY

          Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety data for ADCs in the treatment of patients with NSCLC in the first- and second-line setting, and place these data in the context of current standards of care. She also considers how these data may impact clinical practice in the future.

          The expert

          • Prof. Céline Mascaux, Strasbourg University, Strasbourg, France

            • This touchPODCAST is for HCPs only.

            This activity is funded by an independent medical education grant from AstraZeneca.

            This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

            For further information visit our website: 

            www.touchrespiratory.org/ADCs-in-NSCLC

            22 min
          • Focused insights: Data implications of ADCs in NSCLC treatment

            touchFOCUS for touchONCOLOGY

            Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety data for ADCs in the treatment of patients with NSCLC in the first- and second-line setting, and place these data in the context of current standards of care. She also considers how these data may impact clinical practice in the future.

            The expert

            • Prof. Céline Mascaux, Strasbourg University, Strasbourg, France

              • This touchPODCAST is for HCPs only

              This activity is funded by an independent medical education grant from AstraZeneca.

              This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

              For further information visit our website:

              www.touchoncology.org/ADCs-in-NSCLC

              22 min
            • Collaboration in chronic ITP: Improving quality of life and patient outcomes - touchSYMPOSIUM for touchONCOLOGY

              touchSYMPOSIUM for touchHAEMATOLOGY

              Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, CA, USA. 

              Symposium chair Prof. Cindy Neunert is joined by Dr María Eva Mingot Castellano and Prof. David Kuter to discuss the impact of immune thrombocytopenia (ITP) on patients and review current and emerging treatment strategies.

              • Session 1: Prof. Cindy Neunert considers how ITP affects patients' lives, including the impact on health-related quality of life 
              • Session 2: Dr Mingot Castellano discusses two illustrative patient cases and the application of current management strategies 
              • Session 3: Prof. David Kuter reviews emerging targeted treatment options for ITP, with a focus on their mechanisms of action and the latest data 
              • Session 4: A panel discussion with all three faculty on shared decision-making and collaboration in the clinic 

                • This touchPODCAST is for HCPs in the USA.

                This activity is funded by an independent medical education grant from Sanofi.

                This activity is jointly provided by USF Health and touchIME. 

                For further information visit our website: touchoncologyime.org

                1 hr 21 min
              • Collaboration in chronic ITP: Improving quality of life and patient outcomes - touchSYMPOSIUM for touchHAEMATOLOGY

                touchSYMPOSIUM for touchHAEMATOLOGY

                Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, CA, USA. 

                Symposium chair Prof. Cindy Neunert is joined by Dr María Eva Mingot Castellano and Prof. David Kuter to discuss the impact of immune thrombocytopenia (ITP) on patients and review current and emerging treatment strategies.

                • Session 1: Prof. Cindy Neunert considers how ITP affects patients' lives, including the impact on health-related quality of life 
                • Session 2: Dr Mingot Castellano discusses two illustrative patient cases and the application of current management strategies 
                • Session 3: Prof. David Kuter reviews emerging targeted treatment options for ITP, with a focus on their mechanisms of action and the latest data 
                • Session 4: A panel discussion with all three faculty on shared decision-making and collaboration in the clinic 

                  • This touchPODCAST is for HCPs in the USA.

                  This activity is funded by an independent medical education grant from Sanofi.

                  This activity is jointly provided by USF Health and touchIME. 

                  For further information visit our website: touchhaematologyime.org

                   

                  1 hr 21 min
                • Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchONCOLOGY

                  touchEXPERT FOCUS for touchONCOLOGY

                  Listen to three experts provide insights into the optimal management of neurofibromatosis

                  type 1 (NF1) in paediatric and adult patients, with a focus on plexiform neurofibromas (PNs).
                  Strategies for ensuring the smooth transitioning of paediatric patients into the adult care system are also considered.

                  The experts

                  • Dr AeRang Kim, Children's National Hospital, Washington, DC, USA
                  • Dr Rebecca Brown, University of Alabama School of Medicine, Birmingham, AL, USA
                  • Dr Kaleb Yohay, NYU Langone Health, New York, NY, USA

                    • This touchPODCAST is for healthcare professionals outside of the UK.

                    This activity is funded by an independent medical education grant from Springworks 

                    Therapeutics, Inc.

                    This activity is jointly provided by USF Health and touchIME.

                    For further information visit our website: 

                    https://touchoncologyime.org/expert-focus-management-of-nf1/

                    38 min
                  • Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchNEUROLOGY

                    touchEXPERT FOCUS for touchNEUROLOGY

                    Listen to three experts provide insights into the optimal management of neurofibromatosis

                    type 1 (NF1) in paediatric and adult patients, with a focus on plexiform neurofibromas (PNs).
                    Strategies for ensuring the smooth transitioning of paediatric patients into the adult care system are also considered.

                    The experts

                    • Dr AeRang Kim, Children's National Hospital, Washington, DC, USA
                    • Dr Rebecca Brown, University of Alabama School of Medicine, Birmingham, AL, USA
                    • Dr Kaleb Yohay, NYU Langone Health, New York, NY, USA

                      • This touchPODCAST is for healthcare professionals outside of the UK.

                      This activity is funded by an independent medical education grant from Springworks 

                      Therapeutics, Inc.

                      This activity is jointly provided by USF Health and touchIME.

                      For further information visit our website: 

                      https://touchneurologyime.org/expert-focus-management-of-nf1/

                      38 min
                    • Advancing the treatment of muscle-invasive bladder cancer: Updates on immunotherapy in the perioperative setting

                      touchEXPERT OPINIONS for touchONCOLOGY


                      Listen to an oncologist, urologist and oncology nurse highlight the key data for immunotherapy in the perioperative setting for muscle-invasive bladder cancer, practical considerations for its use in clinical practice, and how possible side effects can be monitored for and managed. They also consider the role of the multidisciplinary team in implementing this treatment modality.

                      The experts

                      • Dr Laura Mertens, Netherlands Cancer Institute, Amsterdam, The Netherlands
                      • Prof. Thomas Powles, Barts Cancer Centre, London, UK
                      • Ms Lindsay Diamond, Icahn School of Medicine at Mount Sinai, New York, NY, USA

                        • This touchPODCAST is for healthcare professionals outside of the UK only.


                        This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. 

                        For further information visit our website: 

                        www.touchONCOLOGY.com 

                        39 min

                      About touchPODCAST

                      From the publisher's feed

                      Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.